Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

October 2028 50

  1. Primary completion Effects of Carnosine In Patients With Peripheral Arterial Disease Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06480760

  2. Study completion Treatment of Acute Ischemic Stroke With Edaravone Dexborneol Sublingual Tablets in Small Vessel Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06674460

  3. Study completion Development and Validation of an Actimetric Protocol to Quantify Physical Activity and Sedentary Behaviour in Post-stroke Subjects Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06943014

  4. Primary completion Development and Validation of an Actimetric Protocol to Quantify Physical Activity and Sedentary Behaviour in Post-stroke Subjects Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06943014

  5. Study completion Butylphthalide for Long-term Efficacy in Minor Stroke Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07230587

  6. Study completion Neuromodulation Combined With Dual FES Cycling and Cognitive Training After Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07807176

  7. Primary completion Neuromodulation Combined With Dual FES Cycling and Cognitive Training After Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07807176

  8. Primary completion Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07827521

  9. Study completion CardioFocus HeartLight Post-Approval Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03168659

  10. Study completion Bimanual Motor Skill Learning in Acute Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05760846

  11. Study completion Initial Double Sequential External Defibrillation in Out of Hospital Cardiac Arrest Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06672159

  12. Primary completion Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06693011

  13. Primary completion Guo&Amp;'s Distal Entry Tear Repair With WeFlow-EndoPatch System (Gallant Study) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06945809

  14. Primary completion Virtue® SAB in the Treatment of Coronary ISR Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07045194

  15. Study completion The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07359599

  16. Primary completion BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07755904

  17. Study completion Pulsed Field Ablation for Paroxysmal Atrial Fibrillation: Clinical Efficacy and Left Atrial Function Protection Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07865221

  18. Study completion Impact of Atrial Fibrillation Prediction Model on Prescribing Oral Anti-Coagulation in Patients With Cryptogenic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07934511

  19. Study completion A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07474649

  20. Study completion Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07205068

  21. Primary completion Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07205068

  22. Study completion Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06492291

  23. Primary completion Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06492291

  24. Primary completion Inhaled Isoflurane for Sedation of Invasively Ventilated Patients With Cardiogenic Shock on Extracorporeal Membrane Oxygenation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07099014

  25. Study completion Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07271186

  26. Primary completion Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07271186

  27. Study completion Flow-diverting Devices for the Treatment of Middle Cerebral Artery Bifurcation Aneurysms Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07372612

  28. Study completion A Extension Study to Evaluate the Safety and Efficacy of HRS-7249 in Patients With Hypertriglyceridemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07799688

  29. Primary completion A Extension Study to Evaluate the Safety and Efficacy of HRS-7249 in Patients With Hypertriglyceridemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07799688

  30. Primary completion A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07843485

  31. Study completion LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05983250

  32. Study completion Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06587737

  33. Study completion Vascular Trial Associated Registry Pilot Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07076082

  34. Primary completion The Prospective, Multicenter, Randomized Controlled Trial of the VentriCure Interventional Left Ventricular Assist System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07675005

  35. Study completion A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07915609

  36. Study completion Post-Approval Study of the TREO Abdominal Stent-Graft System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04697784

  37. Primary completion Post-Approval Study of the TREO Abdominal Stent-Graft System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04697784

  38. Study completion Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06225752

  39. Study completion STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06901466

  40. Study completion Use of PRP in Open Surgery for Type A Aortic Dissection Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07005661

  41. Primary completion Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07511543

  42. Study completion Tenecteplase for Late-Window Stroke Guided by DWI-FLAIR Mismatch Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07540416

  43. Primary completion CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07612774

  44. Study completion Localized Evidence of Cytokine Adsorption Therapy During Pediatric Cardiac Surgery: A Single Center Randomized Controlled Trial (LEAT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07771491

  45. Primary completion Localized Evidence of Cytokine Adsorption Therapy During Pediatric Cardiac Surgery: A Single Center Randomized Controlled Trial (LEAT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07771491

November 2028 37

  1. Study completion The COLchicine and Atrial FIBrillation Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05928728

  2. Primary completion SMART Exercise for PAD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06032065

  3. Primary completion Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07324837

  4. Study completion Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07441200

  5. Primary completion Superficial Parasternal Block Combined With Rectus Sheath Block for Open Cardiac Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07890857

  6. Primary completion Endoscopic Sutured Gastroplasty with Endomina® Device Versus Standard of Care in Patients with Type 2 Diabetes and Class I Obesity: a Multi-center, Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05516576

  7. Primary completion MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06271590

  8. Primary completion A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06458907

  9. Study completion A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07078383

  10. Study completion CGM Use in Non-insulin Patients With DM2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07128342

  11. Primary completion Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07245069

  12. Primary completion Coronary Artery Stents in Heart Failure With Preserved Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07560436

  13. Study completion BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07755904

  14. Primary completion ADVA ACE Coronary Stent System in Coronary Artery Disease Patients (ADVANCE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07912541

  15. Primary completion CLEANer Aspiration for Pulmonary Embolism Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06189313

  16. Primary completion New Heart Imaging Techniques to Evaluate Possible Heart Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01399385

  17. Primary completion A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07301034

  18. Study completion Trial to Assess the Safety and Efficacy of Sirolimus-Coated Balloon vs. Uncoated Standard Angioplasty for the Treatment of Below-the-knee Peripheral Arterial Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04772300

  19. Study completion RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06195540

  20. Primary completion RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06195540

  21. Study completion Impact of Local Tissue Inflammation on Intramyocardial Conduction Pathways Post Percutaneous Valve : Evaluation by Positron Emission Tomography on Exploratory Cohort Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05308888

  22. Primary completion A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06649110

  23. Study completion Ferric Citrate and Chronic Kidney Disease in Children Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04741646

  24. Study completion Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural Tanzania Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06704633

  25. Primary completion Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural Tanzania Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06704633

  26. Study completion Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07102511

  27. Study completion A Multicenter, Randomized, Double-blind, Placebo-controlled Trial on the Treatment of Hypertensive Intracerebral Hemorrhage With Naoxuekang Dropping Pills Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07200921

  28. Primary completion A Multicenter, Randomized, Double-blind, Placebo-controlled Trial on the Treatment of Hypertensive Intracerebral Hemorrhage With Naoxuekang Dropping Pills Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07200921

  29. Primary completion A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07527299

  30. Study completion Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07601763

  31. Study completion PulseMagic™ TrueForce™ PAF NMPA Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07720557

  32. Study completion A Study of BGM0504 in Early T2DM With Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07743983

  33. Study completion Study on Anti-Thrombotic Regimens for Secondary Prevention in Ischemic Stroke Patients With Possible Benefit From Anticoagulation Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07746882

  34. Study completion Evaluating Different Protocols of Non-invasive Brain Stimulation (NIBS) in Stroke Rehabilitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07786649

  35. Primary completion Evaluating Different Protocols of Non-invasive Brain Stimulation (NIBS) in Stroke Rehabilitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07786649

  36. Study completion Superficial Parasternal Block Combined With Rectus Sheath Block for Open Cardiac Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07890857

  37. Study completion Sirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon Treatment (SPRIT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07920055

December 2028 250

  1. Study completion Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05450328

  2. Primary completion A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06168942

  3. Study completion CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06283888

  4. Study completion Home-based Cardiac Rehabilitation in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06349941

  5. Primary completion Home-based Cardiac Rehabilitation in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06349941

  6. Study completion Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06362746

  7. Primary completion A Danish Pragmatic Randomized Trial of Nutritional Supplements in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06694727

  8. Primary completion StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06785727

  9. Primary completion INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06965504

  10. Study completion Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06968806

  11. Primary completion Intravenous Tirofiban After Delayed Thrombolysis in Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07111806

  12. Primary completion Minocycline in Stroke Study at Maimonides Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07237048

  13. Study completion Resuscitation Enhancement to Avoid Rearrest Through Evidence-based Strategies in Prehospital Post-resuscitation Care Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07239908

  14. Study completion Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07276282

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study start Tirofiban for Successful Endovascular Stroke Thrombectomy Registry record

    Expected 2024-07-31; that period ended on 2024-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06373042

  2. Study start Efficacy and Safety of Lactoferrin in Heart Failure Patients Registry record

    Expected 2024-07; that period ended on 2024-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06427200

  3. Study start Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP and Prox BTK-Lesions (JETART) Registry record

    Expected 2024-07; that period ended on 2024-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06434779

  4. Primary completion ACOART BTK RENEW:A Post Market Clinical Study Registry record

    Expected 2024-08-01; that period ended on 2024-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04885985

  5. Primary completion Freestyle Libre and Hospital Admissions in Type 2 Diabetes Registry record

    Expected 2024-08-01; that period ended on 2024-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04997512

  6. Study completion Trial Comparing Immediate Versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation Patients Registry record

    Expected 2024-08-01; that period ended on 2024-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05001074

  7. Primary completion Trial Comparing Immediate Versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation Patients Registry record

    Expected 2024-08-01; that period ended on 2024-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05001074

  8. Study completion The POST-ACS Study Registry record

    Expected 2024-08-01; that period ended on 2024-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05322200

  9. Primary completion Vibration Approach Functions in Upper Extremities for People After Stroke Registry record

    Expected 2024-08-01; that period ended on 2024-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05969249

  10. Study completion Combining Accelerometer, Gyroscope, Sound, Electrocardiography and Photoplethysmography Data in Cardiac Monitoring Registry record

    Expected 2024-08-01; that period ended on 2024-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06422468

  11. Primary completion Combining Accelerometer, Gyroscope, Sound, Electrocardiography and Photoplethysmography Data in Cardiac Monitoring Registry record

    Expected 2024-08-01; that period ended on 2024-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06422468

  12. Study start Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes Registry record

    Expected 2024-08-01; that period ended on 2024-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06439758

  13. Study start Comparison of the Antiplatelet Efficacy of Aspirin Combined With Clopidogrel and Aspirin Combined With Half-dose Ticagrelor in Patients With Unruptured Intracranial Aneurysms With Normal CYP2C19 Metabolizer Phenotype Registry record

    Expected 2024-08-01; that period ended on 2024-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06486363

  14. Study start Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy Registry record

    Expected 2024-08-01; that period ended on 2024-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06501651

  15. Study completion Dapagliflozin Evaluation on Atrial Fibrillation Patients Followed Cox Maze IV Procedure Registry record

    Expected 2024-08-07; that period ended on 2024-08-07.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05816733

  16. Primary completion The Effect of Mankai on Glycemic Control Among Patients With T2D Registry record

    Expected 2024-08-08; that period ended on 2024-08-08.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06416475

  17. Study completion The Effect of Mankai on Glycemic Control Among Patients With T2D Registry record

    Expected 2024-08-15; that period ended on 2024-08-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06416475

  18. Study completion Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study Registry record

    Expected 2024-08-30; that period ended on 2024-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03284255

  19. Primary completion Magnetocardiography in the Accurate Identification of Severe Coronary Lesions and Myocardial Necrosis Registry record

    Expected 2024-08-30; that period ended on 2024-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05392712

  20. Study completion Colchicine Protective Effect in Patients Undergoing Percutaneous Coronary Intervention (COLCHICINE-PROTECT) Registry record

    Expected 2024-08-30; that period ended on 2024-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05739929

  21. Primary completion Colchicine Protective Effect in Patients Undergoing Percutaneous Coronary Intervention (COLCHICINE-PROTECT) Registry record

    Expected 2024-08-30; that period ended on 2024-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05739929

  22. Study start Ticagrelor Versus Cilostazol in Ischemic Stroke Registry record

    Expected 2024-08-30; that period ended on 2024-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06561867

  23. Study completion A Polypill for Secondary Prevention of Ischemic Heart Disease Registry record

    Expected 2024-08; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03541109

  24. Study completion The Vesalio NeVa Stent Retriever Registry Study for Treatment of Large Vessel Occlusion Strokes Registry record

    Expected 2024-08; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03926988

  25. Primary completion The Vesalio NeVa Stent Retriever Registry Study for Treatment of Large Vessel Occlusion Strokes Registry record

    Expected 2024-08; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03926988

  26. Study completion The Vesalio NeVa Stent Retriever Study for Treatment of Large Vessel Occlusion Strokes Registry record

    Expected 2024-08; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03927001

  27. Primary completion The Vesalio NeVa Stent Retriever Study for Treatment of Large Vessel Occlusion Strokes Registry record

    Expected 2024-08; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03927001

  28. Study completion Repository of Phase Signals for Pulmonary Hypertension Algorithm Development Registry record

    Expected 2024-08-31; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04031989

  29. Study completion Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors Registry record

    Expected 2024-08-31; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04191330

  30. Primary completion Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial). Registry record

    Expected 2024-08-31; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04788186

  31. Study completion Effectiveness of a Neuromuscular Exercise Program and Visual Feedback in the Management of Body Position for Stroke Survivors Registry record

    Expected 2024-08-31; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05187559

  32. Primary completion Effectiveness of a Neuromuscular Exercise Program and Visual Feedback in the Management of Body Position for Stroke Survivors Registry record

    Expected 2024-08-31; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05187559

  33. Primary completion Community Glucose Monitoring Project Registry record

    Expected 2024-08-31; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05351190

  34. Study completion Clinical Trial for GNX80 in Intermittent Claudication Registry record

    Expected 2024-08; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05400395

  35. Study completion Safety and Efficacy Study Of The Thoracic Aortic Stent Graft System Treating Aortic Dissection Registry record

    Expected 2024-08; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05430672

  36. Primary completion Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes Registry record

    Expected 2024-08; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05431296

  37. Study completion rTMS in Chronic Poststroke Dysphagia Registry record

    Expected 2024-08-31; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05590819

  38. Primary completion Clinical Validation and Safety of the AC 12L ECG System Against a Standard of Care 12-Lead ECG (AC 12L ECG) Registry record

    Expected 2024-08; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05617001

  39. Study completion Effects of Aerobic Exercise on the Cerebral Arterial System, Cognitive, and Motor Function in Post-stroke Patients. Registry record

    Expected 2024-08; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05706168

  40. Primary completion Effects of Aerobic Exercise on the Cerebral Arterial System, Cognitive, and Motor Function in Post-stroke Patients. Registry record

    Expected 2024-08; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05706168

  41. Study completion Safety and Efficacy of DIDALA Monotherapy in Patients With Type 2 Diabetes Compared With Metformin. Registry record

    Expected 2024-08-31; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05760456

  42. Study completion Cilostazol Dexborneol Versus Placebo for Microcirculation Dysfunction After Reperfusion Therapy in Patients With Acute Ischemic Stroke With Large Vessel Occlusion Registry record

    Expected 2024-08; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05836766

  43. Study completion Vibration Approach Functions in Upper Extremities for People After Stroke Registry record

    Expected 2024-08-31; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05969249

  44. Study completion Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia Registry record

    Expected 2024-08; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06153433

  45. Study completion A Study Evaluating the Safety and Efficacy of Neuroprotective Peptide CN-105 Peptide in Patients With Acute Supratentorial Intracerebral Hemorrhage Registry record

    Expected 2024-08; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06255977

  46. Study start Beta-Blockers in Takotsubo Syndrome Study Registry record

    Expected 2024-08; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06509074

  47. Primary completion The Efficacy and Safety of Low-Level Tragus Stimulation on Heart Rate Variability, Neutrophil-Lymphocyte Ratio, and Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction (TESLA-STEMI) Registry record

    Expected 2024-08-31; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06537583

  48. Study start A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes Registry record

    Expected 2024-08; that period ended on 2024-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06559722

  49. Primary completion Effects of Preferential Left Ventricular Pacing on Ventriculoarterial Coupling and Clinical Course of Heart Failure Registry record

    Expected 2024-09-01; that period ended on 2024-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04420065

  50. Study completion Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion Registry record

    Expected 2024-09-01; that period ended on 2024-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05671276

  51. Primary completion Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion Registry record

    Expected 2024-09-01; that period ended on 2024-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05671276

  52. Study completion Glucocorticoid Treatment in Transaortic Valve Replacement to Reduce the Incidence of Conduction Disturbances (GLUCO-TAVR). Registry record

    Expected 2024-09-01; that period ended on 2024-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06076824

  53. Primary completion Glucocorticoid Treatment in Transaortic Valve Replacement to Reduce the Incidence of Conduction Disturbances (GLUCO-TAVR). Registry record

    Expected 2024-09-01; that period ended on 2024-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06076824

  54. Study completion Three Dimensional Navigation IntraCardiac Guidance Kit for Atrial Septal Puncture Registry record

    Expected 2024-09-01; that period ended on 2024-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06188351

  55. Study start Assessing the Safety and Efficacy of the LAmbre™ Plus Device Registry record

    Expected 2024-09-01; that period ended on 2024-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06465706

  56. Study start Short Term Reproducibility of Office White-coat Effect Registry record

    Expected 2024-09-01; that period ended on 2024-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06523062

  57. Study start Analysis of the Efficacy and Stability of a Wearable ECG Monitor Registry record

    Expected 2024-09-09; that period ended on 2024-09-09.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06546046

  58. Primary completion Combining Aspirin With Ticagrelor or Clopidogrel in Minor Stroke or TIA Registry record

    Expected 2024-09-10; that period ended on 2024-09-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06591312

  59. Primary completion Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA Registry record

    Expected 2024-09-15; that period ended on 2024-09-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06591299

  60. Primary completion Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA Registry record

    Expected 2024-09-15; that period ended on 2024-09-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06591390

  61. Primary completion Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy Registry record

    Expected 2024-09-24; that period ended on 2024-09-24.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05326490

  62. Study completion Del Nido Versus HTK Cardioplegia in Adult Aortic Valve Replacement Registry record

    Expected 2024-09-24; that period ended on 2024-09-24.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06235424

  63. Study completion Combining Aspirin With Ticagrelor or Clopidogrel in Minor Stroke or TIA Registry record

    Expected 2024-09-25; that period ended on 2024-09-25.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06591312

  64. Study completion A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH Registry record

    Expected 2024-09; that period ended on 2024-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03970031

  65. Primary completion A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH Registry record

    Expected 2024-09; that period ended on 2024-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03970031

  66. Primary completion Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator Registry record

    Expected 2024-09; that period ended on 2024-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04504188

  67. Study completion Hemodynamic Optimization of Cerebral Perfusion After Endovascular Therapy in Patients With Acute Ischemic Stroke Registry record

    Expected 2024-09-30; that period ended on 2024-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04892511

  68. Study completion A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus Registry record

    Expected 2024-09-30; that period ended on 2024-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05466643

  69. Primary completion A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus Registry record

    Expected 2024-09-30; that period ended on 2024-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05466643

  70. Study completion The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin Registry record

    Expected 2024-09; that period ended on 2024-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05505994

  71. Study completion AI Health Assistant and Type 2 Diabetes Registry record

    Expected 2024-09-30; that period ended on 2024-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05539066

  72. Primary completion AI Health Assistant and Type 2 Diabetes Registry record

    Expected 2024-09-30; that period ended on 2024-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05539066

  73. Primary completion Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis Registry record

    Expected 2024-09-30; that period ended on 2024-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06071949

  74. Primary completion Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis Registry record

    Expected 2024-09-30; that period ended on 2024-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06072001

  75. Primary completion Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes Registry record

    Expected 2024-09; that period ended on 2024-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06129526

  76. Study start Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh Registry record

    Expected 2024-09; that period ended on 2024-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06449235

  77. Study completion The Efficacy and Safety of Low-Level Tragus Stimulation on Heart Rate Variability, Neutrophil-Lymphocyte Ratio, and Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction (TESLA-STEMI) Registry record

    Expected 2024-09-30; that period ended on 2024-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06537583

  78. Primary completion Atrial Anomalies Predict Silent Atrial Fibrillation Detected by Implantable Cardiac Monitor in Cryptogenic Stroke Registry record

    Expected 2024-09; that period ended on 2024-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06542770

  79. Study start The Effect of Probiotics vs Activated Charcoal in the Management of CKD Patients Suffering From Uremic Pruritus. Registry record

    Expected 2024-09; that period ended on 2024-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06579066

  80. Study completion Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA Registry record

    Expected 2024-09-30; that period ended on 2024-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06591299

  81. Primary completion Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA Registry record

    Expected 2024-09-30; that period ended on 2024-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06591351

  82. Study completion Multi-lead ECG to Effectively Optimize Resynchronization Devices: New CRT Recipients Registry record

    Expected 2024-10-01; that period ended on 2024-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04083690

  83. Primary completion Clinical Outcomes Between Anticoagulation and DAPT Therapy in AF Patients Successfully Undergoing LAAO Registry record

    Expected 2024-10-01; that period ended on 2024-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04135677

  84. Study completion Spider Versus Emboshield Distal Protection on Cerebral Microembolization During Vulnerable Plaque in Carotid Artery Stenting Registry record

    Expected 2024-10-01; that period ended on 2024-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04904250

  85. Study completion High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study Registry record

    Expected 2024-10-01; that period ended on 2024-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05585151

  86. Primary completion Evaluation of Safety and Effectiveness of Lobster Dynamic Interspinous Spacer in Lumbar Spinal Stenosis Registry record

    Expected 2024-10-01; that period ended on 2024-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05587465

  87. Study completion Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA Registry record

    Expected 2024-10-01; that period ended on 2024-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06591390

  88. Study completion Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA Registry record

    Expected 2024-10-10; that period ended on 2024-10-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06591351

  89. Study start Phimume® Percutaneous Left Ventricular Assist System Study Registry record

    Expected 2024-10-14; that period ended on 2024-10-14.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06639321

  90. Study start Remote Multichannel Monitoring of Patients With Chronic DIseAses Using Speech technoLogies Based On Artificial intelliGence Registry record

    Expected 2024-10-15; that period ended on 2024-10-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06644339

  91. Study completion Non-adhesive Liquid Embolic System in the Embolization of Cerebral Arteriovenous Malformations Registry record

    Expected 2024-10-17; that period ended on 2024-10-17.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05058482

  92. Study completion CorVad Percutaneous Ventricular Assist System Study Registry record

    Expected 2024-10-18; that period ended on 2024-10-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06198998

  93. Primary completion CorVad Percutaneous Ventricular Assist System Study Registry record

    Expected 2024-10-18; that period ended on 2024-10-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06198998

  94. Study completion Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES Registry record

    Expected 2024-10-24; that period ended on 2024-10-24.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04135989

  95. Study start Use of App for Stroke Assessment VS Standard Level of Care During Prehospital Stroke Assessment Registry record

    Expected 2024-10-29; that period ended on 2024-10-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06672757

  96. Study completion Clinical Outcomes Between Anticoagulation and DAPT Therapy in AF Patients Successfully Undergoing LAAO Registry record

    Expected 2024-10-30; that period ended on 2024-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04135677

  97. Study completion The Safety and Long-Term Clinical Benefit of PCSK9i in STEMI Patients Registry record

    Expected 2024-10-30; that period ended on 2024-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05579418

  98. Primary completion The Safety and Long-Term Clinical Benefit of PCSK9i in STEMI Patients Registry record

    Expected 2024-10-30; that period ended on 2024-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05579418

  99. Study start Safety and Efficacy of Apixaban Versus Warfarin in Peritoneal Dialysis Patients With Non Valvular Atrial Fibrillation: a Prospective, Randomised, Open-label, Blinded End-point Trial (APIDP2) Registry record

    Expected 2024-10-30; that period ended on 2024-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06045858

  100. Primary completion The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes Registry record

    Expected 2024-10-30; that period ended on 2024-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06408532